Taxol given weekly in advanced previously treated ovarian carcinomas - a pilot study

被引：12

作者：

Andersson, H ^{[1
]}

Horvath, G ^{[1
]}

Mellqvist, L ^{[1
]}

Westberg, R ^{[1
]}

机构：

[1] BRISTOL MYERS SQUIBB,CLIN ONCOL RES DEPT,STOCKHOLM,SWEDEN

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 1997年 / 7卷 / 04期

关键词：

chemotherapy; ovarian cancer; Taxol; weekly;

D O I：

10.1046/j.1525-1438.1997.00449.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In this pilot study, 42 patients with advanced ovarian carcinoma were treated with Taxol weekly instead of every 3 weeks. The initial dose was 67 mg m(-2). The clinical response rate was 29%. The response rate was 22% for patients with platinum-resistant tumors compared to 42% for patients with platinum-sensitive tumors. This difference was not statistically significant. The median progression free survival was 110 days and the median overall survival 341 days. The toxicity was acceptable and probably less pronounced than with the standard triweekly schedule. A randomized multicenter study comparing these two treatment schedules is presently under way in Scandinavia.

引用

页码：262 / 266

页数：5

共 28 条

[11] PHASE-I FEASIBILITY AND PHARMACOLOGICAL STUDY OF WEEKLY INTRAPERITONEAL PACLITAXEL - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY [J].

FRANCIS, P ;

ROWINSKY, E ;

SCHNEIDER, J ;

HAKES, T ;

HOSKINS, W ;

MARKMAN, M .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2961-2967

[12] PHASE-II TRIAL OF DOCETAXEL IN PATIENTS WITH PLATINUM-REFRACTORY ADVANCED OVARIAN-CANCER [J].

FRANCIS, P ;

SCHNEIDER, J ;

HANN, L ;

BALMACEDA, C ;

BARAKAT, R ;

PHILLIPS, M ;

HAKES, T .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) :2301-2308

[13]

GLANTZ MJ, 1995, SEMIN ONCOL, V22, P26

[14] PACLITAXEL (TAXOL) IN RELAPSED AND REFRACTORY OVARIAN-CANCER - THE UK AND EIRE EXPERIENCE [J].

GORE, ME ;

LEVY, V ;

RUSTIN, G ;

PERREN, T ;

CALVERT, AH ;

EARL, H ;

THOMPSON, JM .

BRITISH JOURNAL OF CANCER, 1995, 72 (04) :1016-1019

[15]

Hoekman K, 1995, Ned Tijdschr Geneeskd, V139, P272

[16]

HUININK WWT, 1994, ANN ONCOL, V5, P527

[17] DOSE-INTENSE TAXOL - HIGH RESPONSE RATE IN PATIENTS WITH PLATINUM-RESISTANT RECURRENT OVARIAN-CANCER [J].

KOHN, EC ;

SAROSY, G ;

BICHER, A ;

LINK, C ;

CHRISTIAN, M ;

STEINBERG, SM ;

ROTHENBERG, M ;

ADAMO, DO ;

DAVIS, P ;

OGNIBENE, FP ;

CUNNION, RE ;

REED, E .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (01) :18-24

[18] TAXOL - A UNIQUE ANTINEOPLASTIC AGENT WITH SIGNIFICANT ACTIVITY IN ADVANCED OVARIAN EPITHELIAL NEOPLASMS [J].

MCGUIRE, WP ;

ROWINSKY, EK ;

ROSENSHEIN, NB ;

GRUMBINE, FC ;

ETTINGER, DS ;

ARMSTRONG, DK ;

DONEHOWER, RC .

ANNALS OF INTERNAL MEDICINE, 1989, 111 (04) :273-279

[19] MITOXANTRONE-INDUCED ONYCHOLYSIS [J].

MITCHELL, PLR ;

HARVEY, VJ .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) :243-244

[20]

PADZUR R, 1994, ANN ONCOL, V5, P468

← 1 2 3 →